Sunmax Biotechnology Co., Ltd. (TPEX:4728)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
388.50
-6.50 (-1.65%)
Apr 28, 2026, 1:30 PM CST
-13.28%
Market Cap 21.51B
Revenue (ttm) 2.03B
Net Income (ttm) 725.75M
Shares Out 54.46M
EPS (ttm) 13.31
PE Ratio 29.68
Forward PE n/a
Dividend 12.10 (3.06%)
Ex-Dividend Date Mar 31, 2026
Volume 8,009
Average Volume 16,720
Open 388.50
Previous Close 395.00
Day's Range 388.00 - 389.00
52-Week Range 373.00 - 501.00
Beta -0.11
RSI 46.18
Earnings Date May 12, 2026

About Sunmax Biotechnology

Sunmax Biotechnology Co., Ltd., a biomedical company, develops, manufactures, and markets biomedical grade collagen and skin care product in Taiwan and Mainland China. The company offers dermal fillers, including Sunmax Deusaderm VITAL and Sunmax Deusaderm LIDO Injectable Collagen Gel with Lidocaine. The company was founded in 2001 and is headquartered in Tainan City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4728
Full Company Profile

Financial Performance

In 2025, Sunmax Biotechnology's revenue was 2.03 billion, an increase of 11.45% compared to the previous year's 1.82 billion. Earnings were 725.75 million, an increase of 6.82%.

Financial Statements

News

There is no news available yet.